Article
Fully searchable access to the November 15, 2009 issue
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Zhaoke enrolls first patient in phase 3 trial of cyclosporine ophthalmic gel for dry eye
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
AI-assisted biomarker segmentation offers precision in nAMD disease monitoring
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
50 years of visionary innovation: Leading ophthalmologists reflect on the field’s greatest breakthroughs
Companies announce presentations at upcoming 2025 ARVO Annual Meeting